title: The use of extended perioperative low molecular weight heparin (tinzaparin) to improve disease-free survival following surgical resection of colon cancer:  a pilot randomized controlled trial.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Auer
authors.forename: Adena
authors.initials: A
authors.lastname: Scheer
authors.forename: Philip S
authors.initials: PS
authors.lastname: Wells
authors.forename: Robin
authors.initials: R
authors.lastname: Boushey
authors.forename: Tim
authors.initials: T
authors.lastname: Asmis
authors.forename: Derek
authors.initials: D
authors.lastname: Jonker
authors.forename: Marc
authors.initials: M
authors.lastname: Carrier
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D000368:Aged; D002170:Canada; D003110:Colonic Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D016017:Odds Ratio; D059035:Perioperative Period; D010865:Pilot Projects; D000078222:Tinzaparin; D054556:Venous Thromboembolism / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000601:surgery
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D000078222:Tinzaparin